About this trial
The 'ADAPT' Biobank is a collection of body material and data from patients with or at risk of cardiac arrhythmias who underwent or will undergo (non-) invasive treatment for this disease. Its main objective is to obtain a comprehensive collection of patient information and material to facilitate research and gain better insight into the complex pathophysiology of the different arrhythmias, the multifactorial process, the heterogeneity in clinical presentation, and prognosis.
Bodily material is used for biochemical marker assessments, histological and molecular analyses for research in cardiac arrhythmias.
Eligibility criteria
Qualifiers
Patients visiting the AMC outpatient clinic
MARK AF
INDICO AF
PREDICT AF
Disqualifiers
Age < 18
Unable or unwilling to comply with study procedures
Pregnancy or of childbearing potential without adequate contraception
NYHA class IV heart failure symptoms or left ventricular ejection fraction <35%.
Trial design
Treatments tested in this trial
- Biobank for Left atrial appendage tissue
- Biobank for Blood
- Biobank for One or more of following fat patches: epicardial fat, subcutaneous fat, pericardial fat, visceral fat.
Treatment groups
7
Treatment groupsSee each treatment group below.